share_log

Haemonetics | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(5.6%)

美国血液技术 | SC 13G:超过5%持股股东披露文件-T. Rowe Price Investment Management, Inc.(5.6%)

美股SEC公告 ·  11/14 12:32
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息